Vertex to buy Alpine Immune Sciences for $4.9 billion
Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion.
Vertex Pharmaceuticals will buy Alpine Immune Sciences, a maker of protein-based medicines that harness the immune system, for $4.9 billion.
On Wednesday, UnitedHealth CEO Andrew Witty appeared before Congress to answer for what lawmakers called a “single attack kicked off a cascading series of
The new funding led by General Catalyst and 7wireVentures values Transcarent at $2.2 billion, will be used for AI projects, acquisitions.
The identification of an inverse association between high-density lipoprotein (HDL) cholesterol levels and incident cardiovascular disease events,1 combined with research on the role of HDL…
Measures of biological age have exploded into health research and have fueled hype around consumer tests. But the field of aging has still not settled…
Scientists are frustrated that the USDA again failed to include basic information about H5N1 genetic sequences from cows when the data were released this week.
تستضيف أجسامنا تريليونات الكائنات الحية الدقيقة، التي يفوق عدد خلاياها خلايا الجسم نفسه. وتتكوَّن
The special sauce of primary care will not be saved until the overwhelming number of quality metrics that primary care providers must complete is winnowed…
Violent clashes erupted early on Wednesday morning on the campus of the University of California in Los Angeles between pro-Palestinian protesters and a group of…